Uncategorized

AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data

Published

on

This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for myasthenia gravis.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version